Literature DB >> 1594323

The mammalian glucose transporters.

S U Devaskar1, M M Mueckler.   

Abstract

We have described the properties of glucose transporters expressed in several mammalian tissues and have summarized some of the adaptations that take place involving these molecules in various normal and abnormal states. With the exception of a few cell types, such as adipocytes and skeletal muscle, glucose transport is not a rate-limiting step in cellular glucose metabolism, and other substrates may be equally important for cellular metabolism. Nevertheless, an understanding of the mechanisms behind the regulation of glucose transport in individual tissues may facilitate an understanding of in vivo glucose utilization and clearance processes as they relate to normal and disease states. Although adult studies provide an impetus toward a mechanistic approach in preventing and treating various disease states involving derangements in glucose homeostasis, there remains a need for similar studies in the fetus and newborn. These developmental studies should help unravel the fetal/neonatal responses to normal and abnormal hormonal and substrate milieu.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1594323     DOI: 10.1203/00006450-199201000-00001

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  16 in total

Review 1.  Glucose transporters in diabetic nephropathy.

Authors:  Frank C Brosius; Charles W Heilig
Journal:  Pediatr Nephrol       Date:  2005-02-17       Impact factor: 3.714

2.  Placental glucose transporter 3 (GLUT3) is up-regulated in human pregnancies complicated by late-onset intrauterine growth restriction.

Authors:  C Janzen; M Y Y Lei; J Cho; P Sullivan; B-C Shin; S U Devaskar
Journal:  Placenta       Date:  2013-08-28       Impact factor: 3.481

3.  Fetal ovine skeletal and cardiac muscle transcriptomics are differentially altered by increased maternal cortisol during gestation.

Authors:  Serene Joseph; Bryan Alava; Andrew Antolic; Elaine M Richards; Charles E Wood; Maureen Keller-Wood
Journal:  Physiol Genomics       Date:  2020-03-02       Impact factor: 3.107

4.  gp160, a tissue-specific marker for insulin-activated glucose transport.

Authors:  K V Kandror; P F Pilch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

5.  Hypoxic adaptation engages the CBP/CREST-induced coactivator complex of Creb-HIF-1α in transactivating murine neuroblastic glucose transporter.

Authors:  Shanthie Thamotharan; Nupur Raychaudhuri; Masatoshi Tomi; Bo-Chul Shin; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-15       Impact factor: 4.310

6.  Glucose transporter-1-deficient mice exhibit impaired development and deformities that are similar to diabetic embryopathy.

Authors:  Charles W Heilig; Thomas Saunders; Frank C Brosius; Kelle Moley; Kathleen Heilig; Raymond Baggs; LiRong Guo; David Conner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

7.  Implications of glucose transporter protein type 1 (GLUT1)-haplodeficiency in embryonic stem cells for their survival in response to hypoxic stress.

Authors:  Charles Heilig; Frank Brosius; Brian Siu; Luis Concepcion; Richard Mortensen; Kathleen Heilig; Min Zhu; Richard Weldon; Guimei Wu; David Conner
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

8.  Bidirectional placental transfer ('leak') of L-glucose in control and diabetic rats.

Authors:  C R Thomas; C Lowy
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

9.  Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice.

Authors:  J M Ren; B A Marshall; M M Mueckler; M McCaleb; J M Amatruda; G I Shulman
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

10.  Testicular regulation of neuronal glucose and monocarboxylate transporter gene expression profiles in CNS metabolic sensing sites during acute and recurrent insulin-induced hypoglycemia.

Authors:  Kamlesh V Vavaiya; Sachin A Paranjape; Karen P Briski
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.